点击图片查看原图

Human LILRB2 / CD85d / ILT4 Protein, Fc tag

产品价格: ¥2600.00

最小起订量:暂无 可售数量:暂无

发货时限:
暂无
所在地区:
中国北京
有效期至:
长期有效
最后更新:
2021-05-14 01:30:02
浏览次数:
13
企业信息

产品详情

品牌名称:
ACROBiosystems
货号: CDD-H5259
供应商: ACROBiosystems
数量: In Stock
英文名: Human LILRB2 / CD85d / ILT4 Protein, Fc tag
规格: 100ug/1mg
内毒素:
Less than 1.0 EU per μg by the LAL method.

纯度:
>85% as determined by SDS-PAGE.

活性:
Measured by its binding ability in a functional ELISA. Immobilized Human ANGPTL7, His Tag at 5 μg/mL (100 μL/well) can bind Human LILRB2, Fc Tag (Catalog # CDD-H5259) with a linear range of 0.031-2 μg/mL.

产品背景:
Leukocyte immunoglobulin-like receptor subfamily B member 2 (LILRB2) is also known as CD85 antigen-like family member D (CD85d), Immunoglobulin-like transcript 4 (ILT-4), Monocyte / macrophage immunoglobulin-like receptor 10 (MIR-10), which is a member of the the subfamily B class of LIR receptors. LILRB2 is receptor for class I MHC antigens. LILRB2 recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles. LILRB2 competes with CD8A for binding to class I MHC antigens. LILRB2 / CD85d inhibits FCGR1A-mediated phosphorylation of cellular proteins and mobilization of intracellular calcium ions.

产品描述:
This protein carries a human IgG1 Fc tag at the C-terminus. The protein has a calculated MW of 74.4 kDa. The protein migrates as 110 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
 

SDS-PAGE


Human LILRB2, Fc tag on SDS-PAGE  under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 85%.
温馨提示:不可用于临床治疗。

免责声明

本网页所展示的有关【Human LILRB2 / CD85d / ILT4 Protein, Fc tag】的信息/图片/参数等由的会员【北京百普赛斯生物科技有限公司 】提供,由【生物实验采购网】会员【北京百普赛斯生物科技有限公司 】自行对信息/图片/参数等的真实性、准确性和合法性负责,本平台(本网站)仅提供展示服务,请谨慎交易,因交易而产生的法 律关系及法律纠纷由您自行协商解决,本平台(本网站)对此不承担任何责任。您在本网页可以浏览【Human LILRB2 / CD85d / ILT4 Protein, Fc tag】有关的信息/图片/价格等及提供 【Human LILRB2 / CD85d / ILT4 Protein, Fc tag】的商家公司简介、联系方式等信息。

在您的合法权益受到侵害时,请您致电,我们将竭诚为您服务,感谢您对【生物实验采购网】的关注与支持!

网站首页 | 关于我们 | 联系方式 | 使用协议 | 版权隐私 | 网站地图  |  排名推广  |  广告服务  |  积分换礼  |  网站留言  |  RSS订阅  |  违规举报
 
免责声明:本站有部分内容来自互联网,如无意中侵犯了某个媒体 、公司 、企业或个人等的知识产权,请来电或致函告之,本网站将在规定时间内给予删除等相关处理。